Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Jun;139(6):721-3.
doi: 10.1007/s10517-005-0389-9.

Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice

V N Anisimov  1 , P A Egormin, L M Bershtein, M A Zabezhinskii, T S Piskunova, I G Popovich, A V Semenchenko
Affiliations
Comparative Study

Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice

V N Anisimov et al. Bull Exp Biol Med. 2005 Jun.

Abstract

Transgenic FVB/N female mice carrying HER-2/neu mammary cancer gene received metformin (1200 mg/liter) with drinking water 5 days a week starting from the age of 2 months until natural death. Metformin slightly reduced food consumption, but did not change water consumption and dynamics of weight gain. Mean life span of mice increased by 8% (p<0.05), in 10% long-living mice it was prolonged by 13.1%, and the maximum life span was prolonged by 1 month under the effect of metformin in comparison with the control. The rate of populational aging decreased by 2.26 times. The total incidence of mammary adenocarcinoma and their multiplicity did not change under the effect of metformin, while the latency of tumor development increased and the mean diameter of tumors decreased. Hence, we first demonstrated a geroprotective effect of metformin and its suppressive effect towards the development of mammary tumors.

PubMed Disclaimer

Publication types